nach oben

AIDS and Behavior

Erschienen in:

27.08.2019 | Substantive Review

Behavioral Weight Loss: A Promising Treatment for Obesity in Adults with HIV

verfasst von: Emily Panza, Edward J. Wing, Rena Wing

Erschienen in: AIDS and Behavior | Ausgabe 4/2020

Einloggen, um Zugang zu erhalten

Abstract

Obesity and chronic disease are growing problems among people living with HIV (PLWH) across the globe. While a variety of treatments have been developed to address cardiovascular and metabolic disease among PLWH, few treatments have focused on helping PLWH and obesity lose weight. In the general population, behavioral weight loss interventions (i.e., diet, physical activity, and behavior therapy) are the first-line treatment for adults for whom weight loss is recommended. However, little research has tested whether the benefits of these programs translate to PLWH. This paper highlights the key components of behavioral weight loss programs, their outcomes in the general population and in the few studies of PLWH, and suggestions for tailoring these programs for PLWH. Behavioral weight loss programs are a strong potential treatment for reducing the burden of obesity among PLWH and merit future research attention.

NHLBI AIDS Working Group. Advancing HIV/AIDS research in heart, lung, and blood diseases. Bethesda, MD: NHLBI; 2012.

Tateyama Y, Techasrivichien T, Musumari PM, et al. Obesity matters but is not perceived: a cross-sectional study on cardiovascular disease risk factors among a population-based probability sample in rural Zambia. PLoS ONE. 2018;13(11):e0208176.CrossRefPubMedPubMedCentral

Wand H, Ramjee G. High prevalence of obesity among women who enrolled in HIV prevention trials in KwaZulu-Natal, South Africa: healthy diet and life style messages should be integrated into HIV prevention programs. BMC Public Health. 2013;13(1):159.CrossRefPubMedPubMedCentral

Erlandson KM, Taejaroenkul S, Smeaton L, et al. A randomized comparison of anthropomorphic changes with preferred and alternative efavirenz-based antiretroviral regimens in diverse multinational settings. Open Forum Infect Dis. 2015;2(3):ofv095.CrossRefPubMedPubMedCentral

Thompson-Paul AM, Wei SC, Mattson CL, et al. Obesity among HIV-infected adults receiving medical care in the United States: data from the cross-sectional Medical Monitoring Project and National Health and Nutrition Examination Survey. Medicine. 2015;94(27):e1081.CrossRefPubMedPubMedCentral

Lake JE. The fat of the matter: obesity and visceral adiposity in treated HIV infection. Curr HIV/AIDS Rep. 2017;14(6):211–9.CrossRefPubMedPubMedCentral

Tate T, Willig AL, Willig JH, et al. HIV infection and obesity: where did all the wasting go? Antivir Ther. 2012;17(7):1281.CrossRefPubMedPubMedCentral

Crum-Cianflone N, Tejidor R, Medina S, Barahona I, Ganesan A. Obesity among patients with HIV: the latest epidemic. AIDS Patient Care STDS. 2008;22(12):925–30.CrossRefPubMedPubMedCentral

Jacobson DL, Tang AM, Spiegelman D, et al. Incidence of metabolic syndrome in a cohort of HIV-infected adults and prevalence relative to the US population (National Health and Nutrition Examination Survey). J Acquir Immune Defic Syndr. 2006;43(4):458–66.CrossRefPubMed

10.

Sullivan PW, Morrato EH, Ghushchyan V, Wyatt HR, Hill JO. Obesity, inactivity, and the prevalence of diabetes and diabetes-related cardiovascular comorbidities in the US, 2000–2002. Diabetes Care. 2005;28(7):1599–603.CrossRefPubMed

11.

Willig AL, Overton ET. Metabolic complications and glucose metabolism in HIV infection: a review of the evidence. Curr HIV/AIDS Rep. 2016;13(5):289–96.CrossRefPubMedPubMedCentral

12.

Brown TT, Cole SR, Li X, et al. Antiretroviral therapy and the prevalence and incidence of diabetes mellitus in the multicenter AIDS cohort study. Arch Intern Med. 2005;165(10):1179–84.CrossRefPubMed

13.

Triant VA, Lee H, Hadigan C, Grinspoon SK. Increased acute myocardial infarction rates and cardiovascular risk factors among patients with human immunodeficiency virus disease. J Clin Endocrinol Metab. 2007;92(7):2506–12.CrossRefPubMed

14.

Grinspoon SK. Perspective cardiovascular disease in HIV: traditional and nontraditional risk factors. Top Antivir Med. 2014;22(4):676.PubMed

15.

Taramasso L, Ricci E, Menzaghi B, et al., editors. Weight gain: a possible side effect of all antiretrovirals. Open Forum Infect Dis; 2017. Oxford: Oxford University Press US.

16.

Anema A, Vogenthaler N, Frongillo EA, Kadiyala S, Weiser SD. Food insecurity and HIV/AIDS: current knowledge, gaps, and research priorities. Curr HIV/AIDS Rep. 2009;6(4):224–31.CrossRefPubMedPubMedCentral

17.

Duran A, Almeida L, Segurado A, Jaime P. Diet quality of persons living with HIV/AIDS on highly active antiretroviral therapy. J Hum Nutr Diet. 2008;21(4):346–50.CrossRefPubMed

18.

Vancampfort D, Mugisha J, De Hert M, et al. Global physical activity levels among people living with HIV: a systematic review and meta-analysis. Disabil Rehabil. 2018;40(4):388–97.CrossRefPubMed

19.

Achhra A, Mocroft A, Reiss P, et al. Short-term weight gain after antiretroviral therapy initiation and subsequent risk of cardiovascular disease and diabetes: the D: A: D study. HIV Med. 2016;17(4):255–68.CrossRefPubMed

20.

De Wit S, Sabin CA, Weber R, et al. Incidence and risk factors for new onset diabetes mellitus in HIV infected patients: the D: A: D study. Diabetes Care. 2008;31(6):1224–9.CrossRefPubMed

21.

Becofsky KM, Wing EJ, Wing RR, Richards KE, Gillani FS. Obesity prevalence and related risk of comorbidities among HIV+ patients attending a New England ambulatory centre. Obes Sci Pract. 2016;2(2):123–7.CrossRefPubMedPubMedCentral

22.

Hemkens LG, Bucher HC. HIV infection and cardiovascular disease. Eur Heart J. 2014;35(21):1373–81.CrossRefPubMed

23.

Lake JE, Stanley TL, Apovian CM, et al. Practical review of recognition and management of obesity and lipohypertrophy in human immunodeficiency virus infection. Clin Infect Dis. 2017;64(10):1422–9.CrossRefPubMedPubMedCentral

24.

Jensen MD, Ryan DH, Donato KA, et al. Executive summary: guidelines (2013) for the management of overweight and obesity in adults. Obesity. 2014;22(S2):S5–39.CrossRef

25.

Stradling C, Chen Y-F, Russell T, Connock M, Thomas GN, Taheri S. The effects of dietary intervention on HIV dyslipidaemia: a systematic review and meta-analysis. PLoS ONE. 2012;7(6):e38121.CrossRefPubMedPubMedCentral

26.

Leyes P, Martínez E, Forga MdT. Use of diet, nutritional supplements and exercise in HIV-infected patients receiving combination antiretroviral therapies: a systematic review. Antivir Ther. 2008;13(2):149.PubMed

27.

O’Brien KK, Tynan A-M, Nixon SA, Glazier RH. Effectiveness of aerobic exercise for adults living with HIV: systematic review and meta-analysis using the Cochrane Collaboration protocol. BMC Infect Dis. 2016;16(1):182.CrossRefPubMedPubMedCentral

28.

O’Brien KK, Tynan A-M, Nixon SA, Glazier RH. Effectiveness of Progressive Resistive Exercise (PRE) in the context of HIV: systematic review and meta-analysis using the Cochrane Collaboration protocol. BMC Infect Dis. 2017;17(1):268.CrossRefPubMedPubMedCentral

29.

Panza E, Wing EJ, Lin N, et al., editors. Physician-delivered weight loss counseling for obese HIV+ adults: adherence to 5A’s framework. The Obesity Society Annual Meeting, Nashville; 2018.

30.

Botros D, Somarriba G, Neri D, Miller TL. Interventions to address chronic disease and HIV: strategies to promote exercise and nutrition among HIV-infected individuals. Curr HIV/AIDS Rep. 2012;9(4):351–63.CrossRefPubMedPubMedCentral

31.

Raiten DJ, Mulligan K, Papathakis P, Wanke C. Executive summary—nutritional care of HIV-infected adolescents and adults, including pregnant and lactating women: what do we know, what can we do, and where do we go from here? Am J Clin Nutr. 2011;94(6):1667S–76S.CrossRefPubMedPubMedCentral

32.

Kamitani E, Sipe TA, Higa DH, Mullins MM, Soares J, Project CHAPRS. Evaluating the effectiveness of physical exercise interventions in persons living with HIV: overview of systematic reviews. AIDS Educ Prev. 2017;29(4):347–63.CrossRefPubMedPubMedCentral

33.

Terry L, Sprinz E, Stein R, Medeiros NB, Oliveira J, Ribeiro JP. Exercise training in HIV-1-infected individuals with dyslipidemia and lipodystrophy. Med Sci Sports Exerc. 2006;38(3):411–7.CrossRefPubMed

34.

Fitch K, Abbara S, Lee H, et al. Effects of lifestyle modification and metformin on atherosclerotic indices among HIV-infected patients with the metabolic syndrome. AIDS. 2012;26(5):587.CrossRefPubMed

35.

Fitch KV, Anderson EJ, Hubbard JL, et al. Effects of a lifestyle modification program in HIV-infected patients with the metabolic syndrome. AIDS. 2006;20(14):1843–50.CrossRefPubMed

36.

Webel AR, Moore SM, Longenecker CT, et al. Randomized controlled trial of the SystemCHANGE intervention on behaviors related to cardiovascular risk in HIV+ adults. J Acquir Immune Defic Syndr. 2018;78(1):23–33.CrossRefPubMedPubMedCentral

37.

Saumoy M, Alonso-Villaverde C, Navarro A, et al. Randomized trial of a multidisciplinary lifestyle intervention in HIV-infected patients with moderate-high cardiovascular risk. Atherosclerosis. 2016;246:301–8.CrossRefPubMed

38.

Webb VL, Wadden TA. Intensive lifestyle intervention for obesity: principles, practices, and results. Gastroenterology. 2017;152(7):1752–64.CrossRefPubMed

39.

World Health Organization (WHO). Nutrient requirements for people living with HIV: report of a technical consultation. Geneva: WHO; 2003.

40.

Ditschuneit HH, Flechtner-Mors M, Johnson TD, Adler G. Metabolic and weight-loss effects of a long-term dietary intervention in obese patients. Am J Clin Nutr. 1999;69(2):198–204.CrossRefPubMed

41.

Heymsfield S, Van Mierlo C, Van der Knaap H, Heo M, Frier H. Weight management using a meal replacement strategy: meta and pooling analysis from six studies. Int J Obes. 2003;27(5):537.CrossRef

42.

Astbury NM, Piernas C, Hartmann-Boyce J, Lapworth S, Aveyard P, Jebb SA. A systematic review and meta-analysis of the effectiveness of meal replacements for weight loss. Obes Rev. 2019;20(4):569–87.CrossRefPubMedPubMedCentral

43.

Reeds DN, Pietka TA, Yarasheski KE, et al. HIV infection does not prevent the metabolic benefits of diet-induced weight loss in women with obesity. Obesity. 2017;25(4):682–8.CrossRefPubMed

44.

US Department of Health and Human Services. Physical activity guidelines advisory committee scientific report. Washington, DC: US Department of Health and Human Services; 2018.

45.

Knowler WC, Barrett-Connor E, Fowler SE, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346(6):393–403.CrossRefPubMed

46.

Diabetes Prevention Program Research Group. Achieving weight and activity goals among diabetes prevention program lifestyle participants. Obes Res. 2004;12(9):1426–34.CrossRef

47.

Diabetes Prevention Program Research Group. 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study. Lancet. 2009;374(9702):1677–86.CrossRefPubMedCentral

48.

Look AHEAD Research Group. The look AHEAD study: a description of the lifestyle intervention and the evidence supporting it. Obesity. 2006;14(5):737–52.CrossRef

49.

Look AHEAD Research Group. Long term effects of a lifestyle intervention on weight and cardiovascular risk factors in individuals with type 2 diabetes: four year results of the Look AHEAD trial. Arch Intern Med. 2010;170(17):1566.

50.

Wadden TA, West DS, Neiberg RH, et al. One-year weight losses in the look AHEAD study: factors associated with success. Obesity. 2009;17(4):713–22.CrossRefPubMed

51.

Look AHEAD Research Group. Eight-year weight losses with an intensive lifestyle intervention: the Look AHEAD study. Obesity. 2014;22(1):5–13.CrossRef

52.

Look AHEAD Research Group. Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes. N Engl J Med. 2013;369(2):145–54.CrossRef

53.

Engelson ES, Agin D, Kenya S, et al. Body composition and metabolic effects of a diet and exercise weight loss regimen on obese. HIV-infected women. Metabolism. 2006;55(10):1327–36.CrossRefPubMed

54.

Becofsky K, Wing EJ, McCaffery J, Boudreau M, Wing RR. A randomized controlled trial of a behavioral weight loss program for human immunodeficiency virus–infected patients. Clin Infect Dis. 2017;65(1):154–7.CrossRefPubMedPubMedCentral

55.

Duncan A, Peters B, Rivas C, Goff L. Reducing risk of Type 2 diabetes in HIV: a mixed-methods investigation of the STOP-Diabetes diet and physical activity intervention. Diabet Med. 2019;00:1–10.

56.

Wing RR, Becofsky K, Wing EJ, et al. Behavioral and cardiovascular effects of a behavioral weight loss program for people living with HIV. AIDS Behav. 2019. https://doi.org/10.1007/s10461-019-02503-x.CrossRefPubMedPubMedCentral

57.

Appel LJ, Moore TJ, Obarzanek E, et al. A clinical trial of the effects of dietary patterns on blood pressure. N Engl J Med. 1997;336(16):1117–24.CrossRefPubMed

58.

Centers for Disease Control and Prevention (CDC). HIV surveillance report: 2016, 2017 (Vol 28). http://www.cdc.gov/hiv/library/reports/hiv-surveillance.html.

59.

An Q, Prejean J, McDavid Harrison K, Fang X. Association between community socioeconomic position and HIV diagnosis rate among adults and adolescents in the United States, 2005 to 2009. Am J Public Health. 2013;103(1):120–6.CrossRefPubMedPubMedCentral

60.

Moredich CA, Kessler TA. Physical activity and nutritional weight loss interventions in obese, low-income women: an integrative review. J Midwifery Womens Health. 2014;59(4):380–7.CrossRefPubMed

61.

Greaney ML, Quintiliani LM, Warner ET, et al. Weight management among patients at community health centers: the “Be Fit, Be Well” study. Obes. Weight Manag. 2009;5(5):222–8.CrossRef

62.

Sherr L, Clucas C, Harding R, Sibley E, Catalan J. HIV and depression—a systematic review of interventions. Psychol Health Med. 2011;16(5):493–527.CrossRefPubMed

63.

Earnshaw VA, Chaudoir SR. From conceptualizing to measuring HIV stigma: a review of HIV stigma mechanism measures. AIDS Behav. 2009;13(6):1160.CrossRefPubMedPubMedCentral

64.

Munro S, Dinatale E, Hartley S, StJacques M, Oursler KA. Barriers and health beliefs related to weight management among veterans with human immunodeficiency virus. Mil Med. 2017;182(1–2):1596–602.CrossRef

65.

Galvan FH, Bing EG, Fleishman JA, et al. The prevalence of alcohol consumption and heavy drinking among people with HIV in the United States: results from the HIV cost and services utilization study. J Stud Alcohol. 2002;63(2):179–86.CrossRefPubMed

66.

Cattaneo D, Giacomelli A, Gervasoni C. Loss of control of HIV viremia with OTC weight-loss drugs: a call for caution? Obesity. 2018;26(8):1251–2.CrossRefPubMed

Titel: Behavioral Weight Loss: A Promising Treatment for Obesity in Adults with HIV
verfasst von: Emily Panza
Edward J. Wing
Rena Wing
Publikationsdatum: 27.08.2019
Verlag: Springer US
Erschienen in: AIDS and Behavior / Ausgabe 4/2020
Print ISSN: 1090-7165
Elektronische ISSN: 1573-3254
DOI: https://doi.org/10.1007/s10461-019-02645-y

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren.

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Proximale Humerusfraktur: Auch 100-Jährige operieren?

01.05.2024 DCK 2024 Kongressbericht

Mit dem demographischen Wandel versorgt auch die Chirurgie immer mehr betagte Menschen. Von Entwicklungen wie Fast-Track können auch ältere Menschen profitieren und bei proximaler Humerusfraktur können selbst manche 100-Jährige noch sicher operiert werden.

Die „Zehn Gebote“ des Endokarditis-Managements

30.04.2024 Endokarditis Leitlinie kompakt

Worauf kommt es beim Management von Personen mit infektiöser Endokarditis an? Eine Kardiologin und ein Kardiologe fassen die zehn wichtigsten Punkte der neuen ESC-Leitlinie zusammen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 4/2020

Patients’ Satisfaction with HIV Care Providers in Public Health Facilities in Lusaka: A Study of Patients who were Lost-to-Follow-Up from HIV Care and Treatment

HCV-Related Mortality Among HIV/HCV Co-infected Patients: The Importance of Behaviors in the HCV Cure Era (ANRS CO13 HEPAVIH Cohort)

Behavioral and Cardiovascular Effects of a Behavioral Weight Loss Program for People Living with HIV

Multilevel Barriers to Engagement in the HIV Care Continuum Among Residents of the State of Rhode Island Living with HIV

Neighborhood Matters: Impact on Time Living with Detectable Viral Load for New Adult HIV Diagnoses in South Carolina